Taxation of Pharmacies in Zimbabwe.

A Comprehensive Tax and Audit Analysis of Pharmacies in Zimbabwe

Overview

The pharmaceutical sector occupies a critical juncture in the national healthcare ecosystem and commercial landscape. Operating as a hybrid of retail trade, professional healthcare service provision, and stringent regulatory compliance under the Medicines and Allied Substances Control Act [Chapter 15:03], pharmacies present a uniquely complex profile for tax administration.

Evaluating the tax health of a pharmacy requires looking beyond standard financial statements. It demands an appreciation of multi-currency accounting challenges, inventory turnover dynamics, professional licensing frameworks under the Health Professions Act [Chapter 27:19], and the operational reality of utilizing temporary professional cover—commonly known as locums.

This article unpacks the primary tax obligations affecting pharmacies, isolates the principal audit red flags that trigger scrutiny from the Zimbabwe Revenue Authority (ZIMRA), and synthesizes statutory provisions from the Income Tax Act [Chapter 23:06], the Finance Act [Chapter 23:04], and pertinent Tax Court and High Court jurisprudence.

The “Locum” Dilemma

In pharmaceutical practice, a locum (short for locum tenens, meaning “placeholder” or “substitute”) refers to a qualified and registered pharmacist who temporarily fills in for a resident, managing, or proprietary pharmacist during absences caused by leave, illness, or peak workload demands.

From a tax and labor governance perspective, the characterization of a locum creates distinct compliance obligations:

• Independent Contractor vs. Employee: A central point of contention in tax audits is whether a locum operates as an independent contractor rendering professional services or as an employee subject to Pay-As-You-Earn (PAYE). If a pharmacy exercises extensive behavioral and financial control—setting rigid fixed hours, providing all operational equipment, and integrating the locum permanently into the core administrative hierarchy—ZIMRA may recharacterize the locum arrangement as an employment relationship.
• Withholding Tax Implications: Where the locum is engaged as an independent corporate entity or sole trader billing for professional services, the payment may attract Non-Residents’ Tax on Fees or general withholding provisions if applicable. However, if classified as an employee under the Thirteenth Schedule of the Income Tax Act, the pharmacy is mandated to deduct PAYE at source via the formal payroll system. Misclassifying regular locums as casual expense-voucher payouts without PAYE deduction is a frequent audit trigger.

Core Taxes Frequent in Pharmacies

Pharmacies are subject to a robust suite of fiscal impositions spanning direct and indirect taxation.

Income Tax (Corporate and Individual Tax)

Governed by Section 7 of the Income Tax Act as read with Chapter II of the Finance Act, pharmacies trading as corporate entities are subject to standard corporate income tax rates. Sole proprietorships and partnerships are taxed on progressive marginal rates.

Under Section 4A of the Finance Act [Chapter 23:04], where a pharmacy receives or accrues income in foreign currency (such as USD), tax must be accounted for and remitted in the corresponding foreign currency, subject to statutory multi-currency blending rules where foreign currency receipts exceed specified thresholds.

Value Added Tax (VAT)

The application of VAT in pharmacies is nuanced:

• Exempt and Zero-Rated Supplies: Many essential medicines and pharmaceutical products are classified as zero-rated or exempt under the Value Added Tax Act [Chapter 23:12], aiming to cushion healthcare consumers.
• Standard-Rated Supplies: Over-the-counter (OTC) cosmetics, lifestyle supplements, nutritional beverages, and general retail merchandise are subject to standard-rated VAT.
• The Audit Risk: A failure to correctly segregate zero-rated/exempt pharmaceutical sales from standard-rated front-shop retail sales distorts output tax declarations, inviting comprehensive VAT audits.

Pay-As-You-Earn (PAYE) and Employment Taxes

Pharmacies typically maintain a mixed workforce comprising registered pharmacists, pharmacy technicians, cashiers, and administrative staff. Remuneration packages frequently include basic salaries, housing allowances, and medical aid contributions. Strict adherence to monthly payroll submissions via the Thirteenth Schedule is mandatory.

Intermediated Money Transfer Tax (IMTT)

Given the high volume of electronic point-of-sale (POS) transactions, mobile money transfers, and digital settlements in modern retail pharmacies, IMTT under Section 36G of the Income Tax Act (and Section 22G of the Finance Act) represents a substantial transactional cost. Reconciling bank statements with ledger turnovers is critical to ensure accurate IMTT remittance without underreporting.

Red Flags 

ZIMRA utilizes sophisticated risk-profiling models and data-matching algorithms to identify anomalies in tax returns. The following are the core red flags specific to the pharmaceutical industry:

Gross Profit Margin Disconnects

• The Issue: Pharmaceutical wholesale and retail margins typically operate within predictable industry benchmarks. A pharmacy reporting unusually low gross profit margins—or consistent trading losses alongside high inventory turnover—signals potential revenue suppression, unrecorded cash sales, or stock shrinkage that has been improperly accounted for.
• Audit Exposure: ZIMRA auditors will cross-examine purchases against declared sales, demanding reconciliation of stock control ledger cards, physical stock counts at financial year-end, and supplier invoices.

Discrepancies Between Point-of-Sale (Fiscalised) Data and Financial Returns

• The Issue: The statutory requirement for fiscal memory device integration means that daily sales data is captured electronically. A mismatch between the gross sales reflected on ZIMRA-interfaced fiscal machines and the figures declared in income tax and VAT returns is an immediate red flag.
• Audit Exposure: Direct invocation of Section 4A(5) of the Finance Act, empowering the Commissioner to deem income or invoke stringent estimations where books of account are found unreliable or falsified.

Misclassification of Professional Fees vs. Payroll (Locum Payments)

• The Issue: Disbursing substantial sums to locum pharmacists under “professional consultancy” or “general expenses” ledger accounts without deducting PAYE or supporting tax clearance certificates.
• Audit Exposure: Assessment for unremitted PAYE, compounded by statutory penalties and interest levied under Section 71 of the Income Tax Act.

Unsubstantiated Stock Write-Offs and Expiry Losses

• The Issue: Pharmacies inevitably deal with expired or damaged pharmaceuticals. Claiming massive deductions for stock write-offs without maintaining certified destruction certificates, regulatory board oversight records (e.g., Medicines Control Authority of Zimbabwe protocols), and contemporaneous stock destruction logs will trigger immediate disallowance.
• Legal Principle: Under general income tax principles, deductions are only allowable if incurred in the production of income and adequately proven. Unsupported write-offs fail the evidentiary burden.

Lessons from the Courts

Tax litigation in Zimbabwe reinforces the strict interpretation of revenue statutes and underscores the judiciary’s backing of ZIMRA’s investigative powers when taxpayer records are deficient.

• Burden of Proof: In alignment with established tax court tenets, the onus rests squarely on the taxpayer to prove that an assessment issued by the Commissioner is excessive or incorrect (Section 65 of the Income Tax Act). In pharmacy audits, assertions regarding “spoilt stock” or “exempt medicine ratios” must be backed by pristine documentation.
• Multi-Currency Compliance and Deeming Provisions: As observed in landmark cases concerning foreign currency compliance (such as Delta Corporation Limited v ZIMRA and related currency disputes), taxpayers must meticulously distinguish local currency transactions from foreign currency streams. Under Section 4A(5) of the Finance Act, if a taxpayer maintains flawed records or attempts to conceal foreign currency receipts, the Commissioner is legally fortified to deem the entirety of trade receipts as foreign currency-denominated—a catastrophic outcome for cash-flow viability.

Conclusion

Tax compliance for pharmacies requires meticulous internal controls, clear demarcation of inventory categories, robust payroll governance for permanent staff and locums alike, and absolute alignment between fiscalised machine outputs and tax filings. By proactively monitoring gross profit margins, substantiating stock write-offs, and respecting the strictures of the Income Tax Act and Finance Act, pharmacy operators can insulate their enterprises from aggressive audit adjustments and punitive statutory penalties.